Home / Infectious Disease & Vaccines
Infectious Disease & Vaccines
| 5 min read
While faster reviews could bring life-saving treatments to patients sooner, compressed timelines could also limit regulatory scrutiny and strain FDA resources.
| 2 min read
The approach pairs ultrasound-induced tumor cell death with real-time antigen capture to drive both local and systemic immune responses.
| 4 min read
Billion-dollar partnerships, Phase 1 wins, AI regulatory tools, and more led the news this week.
| 4 min read
FDA updates, pharma tariff agreements, gene editing deals, and more led the news this week.
| 4 min read
New vaccines and antiviral injections that could offer significantly better and broader protection against the flu are now in clinical trials.
| 6 min read
A century after the first vaccine, tuberculosis still claims over a million lives a year, but promising research could change the story.
| 3 min read
How a team at Pfizer turned a decade-old compound into the fastest small molecule drug for COVID-19.
| 4 min read
Researchers are turning bacterial transport systems from obstacles into opportunities for targeted therapy.
| 4 min read
Scientists are using insights from viral hijacking to chemically reprogram E3 ligases, opening new opportunities in drug discovery.
| 2 min read
Lonza strengthens its pharmaceutical quality control portfolio through the acquisition of Redberry, enabling faster and more reliable microbial testing.
| 2 min read
Enamine’s chemistry platform delivered over 2,000 novel compounds to accelerate the discovery of pre-clinical candidate ASAP-0017445.
| 6 min read
Vaxart aims to revolutionize immunization by replacing injections with easy-to-take tablets.
